Why Is Mirum Pharmaceuticals Down 0.7 percent Since Last Earnings Report?
| EXAS Stock | USD 57.25 0.32 0.56% |
Slightly above 61% of EXACT Sciences' investor base is looking to short. The analysis of the overall investor sentiment regarding EXACT Sciences suggests that many traders are alarmed. EXACT Sciences' investing sentiment can be driven by a variety of factors including economic data, EXACT Sciences' earnings reports, geopolitical events, and overall market trends.
EXACT |
Mirum Pharmaceuticals reported earnings 30 days ago. Whats next for the stock We take a look at earnings estimates for some clues.
Read at zacks.com
 |
EXACT Sciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards EXACT Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
EXACT Sciences Maximum Pain Price Across January 17th 2025 Option Contracts
EXACT Sciences' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of EXACT Sciences close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of EXACT Sciences' options.
EXACT Sciences Fundamental Analysis
We analyze EXACT Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXACT Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXACT Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
EXACT Sciences is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
EXACT Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EXACT Sciences stock to make a market-neutral strategy. Peer analysis of EXACT Sciences could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics with similar companies.
Peers
EXACT Sciences Related Equities
| GH | Guardant Health | 6.26 | ||||
| TWST | Twist Bioscience | 4.46 | ||||
| NTRA | Natera | 4.36 | ||||
| ILMN | Illumina | 3.88 | ||||
| CDNA | Caredx | 3.76 | ||||
| DHR | Danaher | 2.19 | ||||
| CSTL | Castle Biosciences | 2.03 | ||||
| TMO | Thermo Fisher | 1.81 | ||||
| CRL | Charles River | 1.73 | ||||
| A | Agilent Technologies | 1.69 | ||||
| MYGN | Myriad Genetics | 1.26 |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.